SSUR Stock Overview
StatSure Diagnostic Systems, Inc. develops, manufactures, and markets rapid in-vitro assays for use in the detection of infectious diseases and other conditions in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
StatSure Diagnostic Systems, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0002 |
| 52 Week High | US$0.0002 |
| 52 Week Low | US$0.0002 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -99.40% |
| 5 Year Change | n/a |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| SSUR | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -0.5% | 1.6% |
| 1Y | n/a | -1.0% | 25.1% |
Return vs Industry: Insufficient data to determine how SSUR performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how SSUR performed against the US Market.
Price Volatility
| SSUR volatility | |
|---|---|
| SSUR Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.8% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SSUR has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SSUR's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | n/a | Mo Bodner | www.statsurediagnostics.com |
StatSure Diagnostic Systems, Inc. develops, manufactures, and markets rapid in-vitro assays for use in the detection of infectious diseases and other conditions in the United States and internationally. The company offers SURE CHECK HIV 1/2 and Clearview Complete HIV 1/ 2 tests, which are single-use diagnostic tests for visual detection of antibodies to HIV 1 and HIV 2. It also provides medical specimen collection devices.
StatSure Diagnostic Systems, Inc. Fundamentals Summary
| SSUR fundamental statistics | |
|---|---|
| Market cap | US$14.71k |
| Earnings (TTM) | US$235.07k |
| Revenue (TTM) | US$1.00m |
0.0x
P/E Ratio0.0x
P/S RatioIs SSUR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SSUR income statement (TTM) | |
|---|---|
| Revenue | US$1.00m |
| Cost of Revenue | US$235.50k |
| Gross Profit | US$765.25k |
| Other Expenses | US$530.18k |
| Earnings | US$235.07k |
Last Reported Earnings
Jun 30, 2008
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did SSUR perform over the long term?
See historical performance and comparison